104 related articles for article (PubMed ID: 24584218)
1. Radiation protection procedures in 131I treatments for thyroid cancer in patients requiring hemodialysis.
Fioroni F; Sghedoni R; Grassi E; Piccagli V; Sollini M; Filice A; Versari A; Iori M
Nucl Med Commun; 2014 Jun; 35(6):626-30. PubMed ID: 24584218
[TBL] [Abstract][Full Text] [Related]
2. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
Modarresifar H; Almodovar S; Bass WB; Ojha B
Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
[TBL] [Abstract][Full Text] [Related]
3. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
Murcutt G; Edwards J; Boakye J; Davenport A
Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
[TBL] [Abstract][Full Text] [Related]
4. Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications.
Courbon F; Caselles O; Zerdoud S; Duthil P; Regis H; Berry I; Caron P
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):363-70. PubMed ID: 17043635
[TBL] [Abstract][Full Text] [Related]
5. [Hemodialysis procedure in a patient treated with radioactive iodine].
Brunet P; Bourrelly M; Mundler O; Bouvier C; Faure V; Opris A; Bouchouareb D; Indreies M; Ramananarivo P; Dussol B; Berland Y
Nephrol Ther; 2008 Jun; 4(3):196-201. PubMed ID: 18272443
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis in patients requiring 131I treatment for thyroid carcinoma.
Fofi C; Festuccia F; Barberi S; Apponi F; Chiacchiararelli L; Scopinaro F; Punzo G; Menè P
Int J Artif Organs; 2013 Jun; 36(6):439-43. PubMed ID: 23653300
[TBL] [Abstract][Full Text] [Related]
7. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
Pahlka RB; Sonnad JR
Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
[TBL] [Abstract][Full Text] [Related]
8. Radioactivity of blood samples taken from thyroidectomized thyroid carcinoma patients after therapy with (131)I.
Larkin A; Millan E; Noz M; Wagner S; Friedman K; Blum M
Thyroid; 2011 Sep; 21(9):1009-12. PubMed ID: 21834682
[TBL] [Abstract][Full Text] [Related]
9. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
Al-Shakhrah IA
Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
[TBL] [Abstract][Full Text] [Related]
10. Radioactive 131I use in end-stage renal disease: nightmare or nuisance?
Sinsakul M; Ali A
Semin Dial; 2004; 17(1):53-6. PubMed ID: 14717812
[TBL] [Abstract][Full Text] [Related]
11. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
12. Radiation safety considerations for post-iodine-131 thyroid cancer therapy.
Culver CM; Dworkin HJ
J Nucl Med; 1992 Jul; 33(7):1402-5. PubMed ID: 1613585
[TBL] [Abstract][Full Text] [Related]
13. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
[TBL] [Abstract][Full Text] [Related]
14. Radiation safety precautions in the management of the hospitalized (131)I therapy patient.
Thompson MA
J Nucl Med Technol; 2001 Jun; 29(2):61-6; test 74-5. PubMed ID: 11376097
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer radioiodine therapy: health service performance and radiation safety.
Vogiatzi S; Liossis A; Lamprinakou M
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):434-8. PubMed ID: 25809109
[TBL] [Abstract][Full Text] [Related]
16. [Management of iodine-131 ablation therapy for thyroid carcinoma in a patient on chronic hemodialysis].
Zenasni N; Elkhayat S; Taleb S; Zamd M; Medkouri G; Benghanem Gharbi M; Ramdani B; Aschawa H; Guensi A
Nephrol Ther; 2015 Apr; 11(2):114-7. PubMed ID: 25709102
[TBL] [Abstract][Full Text] [Related]
17. Radiation protection consequences of the care of a terminally ill patient having received a thyroid ablation dose of 131I-sodium iodide.
Griffiths PA; Jones GP; Marshall C; Powley SK
Br J Radiol; 2000 Nov; 73(875):1209-12. PubMed ID: 11144800
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis.
Holst JP; Burman KD; Atkins F; Umans JG; Jonklaas J
Thyroid; 2005 Dec; 15(12):1321-31. PubMed ID: 16405403
[TBL] [Abstract][Full Text] [Related]
19. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study on the transition of radiation dose rate and iodine distribution in patients with I-131-treated well-differentiated thyroid cancer to improve bed control shorten isolation periods.
Yama N; Sakata K; Hyodoh H; Tamakawa M; Hareyama M
Ann Nucl Med; 2012 Jun; 26(5):390-6. PubMed ID: 22382609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
